Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment. - Larsen,J.; Hylleberg,B.; Ng,K.; Damsbo,P. (Diabetes Care, 2001)